Federico Grossi, CHIEF MEDICAL OFFICER at Apellis Pharmaceuticals, Inc. (APLS), sold 625 shares at $30.70 ($19K) on 2021-11-01, disclosed to the SEC on 2021-11-02.
Scheduled sale ($19k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2022-11-03 | $152K | — | Filing → |
| APLS | SELL | 2022-10-05 | $167K | — | Filing → |
| APLS | SELL | 2022-09-02 | $151K | — | Filing → |